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Although intensive efforts have been undertaken to elucidate the genetic background of immunoglobulin A ne-
phropathy (IgAN), genetic factors associated with the pathogenesis of this disease are still not well understood.
We designed a case-control association study that was based on linkage disequilibrium among single-nucleotide
polymorphisms (SNPs) in the selectin gene cluster on chromosome 1q24-25, and we found two SNPs in the E-
selectin gene (SELE8 and SELE13) and six SNPs in the L-selectin gene (SELL1, SELL4, SELL5, SELL6, SELL10,
and SELL11) that were significantly associated with IgAN in Japanese patients. All eight SNPs were in almost
complete linkage disequilibrium. SELE8 and SELL10 caused amino acid substitutions from His to Tyr and from
Pro to Ser ( , , odds ratio p 2.73 [95% confidence interval {CI} 1.38–5.38] for His-to-Tyr2x p 9.02 Pp .0026
substitutions; , , odds ratio p 3.61 [95% CI 1.91–6.83] for Pro-to-Ser substitutions), and2x p 17.4 Pp .000031
SELL1 could affect promoter activity of the L-selectin gene ( , , odds ratio p 3.77 [95%2x p 19.5 Pp .000010
CI 2.02–7.05]). The TGT haplotype at these three loci was associated significantly with IgAN ( ,2x p 18.67 Pp
, odds ratio p 1.88 [95% CI 1.41–2.51]). Our results suggest that these eight SNPs in selectin genes may.000016
be useful for screening populations susceptible to the IgAN phenotype that involves interstitial infiltration.
Immunoglobulin A nephropathy (IgAN [MIM 161950])
is the most common form of glomerulonephritis, a prin-
cipal cause of end-stage renal disease worldwide (Mai-
sonneuve et al. 2000). Surveys of patients with primary
glomerulonephritis that were conducted in 1985 and
1993 by the Research Group on Progressive Renal Dis-
eases in Japan revealed a high prevalence of IgAN and
a relatively poor prognosis for patients (Koyama et al.
1997). The rate of survival for the 502 patients with
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IgAN who were monitored, with renal-related death
taken as the end point, was 61% at 20 years from the
time renal abnormalities were first detected. The strong
evidence from human studies of a role for genetic factors
in the development and progression of IgAN has been
provided by descriptive reports of familial aggregations
of IgAN and by analyses of affected sib pairs and parent-
child pairs frommultiple ethnic groups (Hsu et al. 2000).
Accumulation of leukocytes within the glomerulus
and interstitium of the kidney is considered to be a key
pathogenetic mechanism in various types of glomeru-
lonephritis (Adler and Brady 1999). The three major
groups of adhesion molecules involved in these inter-
actions are the selectins, the integrins, and certain pro-
teins belonging to the immunoglobulin supergene family.
To date, three selectins have been characterized: E-se-
lectin is expressed predominantly in cytokine-activated
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Figure 1 High-density map and association with IgAN of SNPs in the selectin gene cluster at chromosome 1q24-25. SNPs (downward
arrows) are numbered for E-selectin (SELE1–13), L-selectin (SELL1–15), and P-selectin (SELP1–6), in the telomeric to centromeric direction.
endothelium, L-selectin in circulating leukocytes, and P-
selectin in activated endothelial cells and platelets. Chau-
dhury et al. (1996) reported a marked increase in E-
selectin and P-selectin expression on the extraglomerular
vascular endothelium, with prominent interstitial infil-
trates, in some biopsy samples from patients with IgAN;
and a large number of L-selectin–positive cells were pre-
sent within glomerular and interstitial infiltrates in af-
fected kidneys. Lai et al. (1994) demonstrated an ap-
parent increase in serum levels of E-selectin that was
associated with increased histopathologic grade, when
patients with IgAN were stratified according to the se-
verity of their glomerular and interstitial lesions. More-
over, increased expression of E-selectin has been ob-
served on renal interstitium that contains lymphocytes
and macrophages, along with an increase in circulating
soluble L-selectin (Kennel-De March et al. 1999).
Single-nucleotide polymorphisms (SNPs) in the hu-
man genome have great potential for application to as-
sociation studies of complex diseases (Kruglyak 1999).
Because SNPs are the most frequent type of genetic var-
iation, we have been screening SNPs on a genomewide
scale to clarify various complex diseases, including
IgAN. For the work reported here, we designed a case-
control association study, using SNPs found in the se-
lectin genes (GenBank), and estimated haplotypes that
might serve to identify regions containing loci respon-
sible for IgAN phenotypes (Takeoka et al. 2001).
Peripheral blood samples were obtained from 346 pa-
tients (196 female and 150 male, mean age 44 years)
who were diagnosed with IgAN on the basis of clinical
manifestations as well as renal-biopsy findings at several
surgical centers in Japan (Department of Medicine, Kid-
ney Center, Tokyo Women’s Medical University; De-
partment of Urology, Iwate Medical University; De-
partment of Urology, Sanai Hospital; Department of
Urology, Iwate Prefectural Ofunato Hospital; and De-
partment of Medicine, Niigata University School of
Medicine). The mean value of serum creatinine at the
time of renal biopsy was 1.07 mg/dl, ranging from 0.3
to 2.5 mg/dl. We analyzed blood from 408 control sub-
jects randomly selected from population-based volun-
teers. DNA was prepared from each sample, according
to standard protocols.
SNPs in the three selectin genes were screened ac-
cording to methods described elsewhere (Ohnishi et al.
2000; Yamada et al. 2000). Information about each SNP
we discovered can be obtained at the Japanese SNPs
(JSNP) Web site.
We amplified multiple genomic fragments, using 20
ng of genomic DNA for each PCR, as described else-
where (Ohnishi et al. 2001). Sequences of the primers
Table 1
Statistically Significant Differences in Eight SNPs among Patients with IgAN versus Control Subjects
NO. [%] OF SUBJECTS WITH
ZYGOSITY SELE8 SELE13 SELL1 SELL4 SELL5 SELL6 SELL10 SELL11
IgAN:
Major homozygotes 187 [57.89%] 189 [57.27%] 185 [54.41%] 157 [45.38%] 166 [48.26%] 133 [46.18%] 156 [53.24%] 161 [57.50%]
Heterozygotes 109 [33.75%] 115 [34.85%] 114 [33.53%] 138 [39.88%] 131 [38.08%] 106 [36.81%] 101 [34.47%] 95 [33.93%]
Minor homozygotes 27 [8.36%] 26 [7.88%] 41 [12.06%] 51 [14.74%] 47 [13.66%] 49 [17.01%] 36 [12.29%] 24 [8.57%]
Total 323 [100.00%] 330 [100.00%] 340 [100.00%] 346 [100.00%] 344 [100.00%] 288 [100.00%] 293 [100.00%] 280 [100.00%]
Major allele 483 [74.77%] 493 [74.70%] 484 [71.18%] 452 [65.32%] 463 [67.30%] 372 [64.58%] 413 [70.48%] 417 [74.46%]
Minor allele 163 [25.23%] 167 [25.30%] 196 [28.82%] 240 [34.68%] 225 [32.70%] 204 [35.42%] 173 [29.52%] 143 [25.54%]
Total 646 [100.00%] 660 [100.00%] 680 [100.00%] 692 [100.00%] 688 [100.00%] 576 [100.00%] 586 [100.00%] 560 [100.00%]
Control
Major homozygotes 269 [66.92%] 274 [67.16%] 246 [61.65%] 218 [53.96%] 227 [56.05%] 218 [58.76%] 235 [62.67%] 262 [67.88%]
Heterozygotes 120 [29.85%] 121 [29.66%] 139 [33.53%] 159 [39.36%] 154 [38.02%] 132 [35.58%] 126 [33.60%] 112 [29.02%]
Minor homozygotes 13 [3.23%] 13 [3.19%] 14 [3.51%] 27 [6.68%] 24 [5.93%] 21 [5.66%] 14 [3.73%] 12 [3.11%]
Total 402 [100.00%] 408 [100.00%] 399 [100.00%] 404 [100.00%] 405 [100.00%] 371 [100.00%] 375 [100.00%] 386 [100.00%]
Major allele 658 [81.84%] 669 [81.99%] 631 [79.07%] 595 [73.64%] 608 [75.06%] 568 [76.55%] 596 [79.47%] 636 [82.38%]
Minor allele 146 [18.16%] 147 [18.01%] 167 [20.93%] 213 [26.36%] 202 [24.94%] 174 [23.45%] 154 [20.53%] 136 [17.62%]
Total 804 [100.00%] 816 [100.00%] 798 [100.00%] 808 [100.00%] 810 [100.00%] 742 [100.00%] 750 [100.00%] 772 [100.00%]
Table 2
Statistically Significant Differences in Eight SNPs among Patients with IgAN versus Control Subjects
STATISTICAL SIGNIFICANCE IN SUBJECTS WITH
STRATIFIED COMPARISON SELE8 SELE13 SELL1 SELL4 SELL5 SELL6 SELL10 SELL11
x2:
Allele frequency 10.686095 11.572843 12.354986 12.242864 11.007155 22.701719 14.379202 12.292278
Genotype frequency (2 # 3) 11.704698 11.980555 19.773932 14.392873 13.899272 24.560263 18.609493 12.969646
Major homozygotes/others 6.244945 7.624198 3.961227 5.494191 4.530285 10.306812 6.018957 7.538820
Minor homozygotes/others 9.025162 8.026010 19.481165 12.982878 12.975893 22.013996 17.377607 9.470623
P:
Allele frequency .001079 .000669 .000440 .000467 .000908 .000002 .000149 .000455
Genotype frequency (2# 3) .002873 .002503 .000051 .000749 .000959 .000005 .000091 .001526
Major homozygotes/others .012455 .005759 .046560 .019080 .033300 .001325 .014153 .006038
Minor homozygotes/others .002663 .0046111 .000010 .000314 .000316 .000003 .000031 .002088
Note — The x2 test was used to evaluate possible associations between different genotypes, allele frequencies, or patients.
784 Am. J. Hum. Genet. 70:781–786, 2002
Table 3
LD Coefficients between Eight SNPs
SELE8 SELE13 SELL1 SELL4 SELL5 SELL6 SELL10
SELL11 .95284 .95969 .85654 .73947 .78009 .80668 .97308
SELL10 .85928 .88022 .93324 .82487 .87217 .89132
SELL6 .77048 .78813 .87736 .89847 .94944
SELL5 .76206 .78182 .88943 .95107
SELL4 .72427 .74805 .85863
SELL1 .84004 .86222
SELE13 .95929
NOTE.—LD coefficients were calculated and expressed as the D′pD/Dmax, as de-
scribed elsewhere (Devlin and Risch 1995)
Table 4
Estimated Haplotype Frequencies of SNPs SELE8, SELL1, and
SELL10
Haplotype IgAN Control Total
CAC 374.55 [68.10%] 568.9 [81.97%] 943.45 [75.84%]
CAT 6.05 [1.10%] 2.01 [.29%] 8.06 [.65%]
CGC 9.9 [1.80%] 2.02 [.29%] 11.92 [.96%]
CGT 20.9 [3.80%] 17.07 [2.46%] 37.97 [3.05%]
TAC 3.3 [.60%] 3.09 [.45%] 6.39 [.51%]
TAT 3.3 [.60%] .03 [.00%] 3.33 [.27%]
TGC 0 [.00%] .98 [.14%] .98 [.08%]
TGTa 132 [24.00%] 99.9 [14.39%] 231.9 [18.64%]
Total 550 [100.00%] 694 [100.00%] 1,244 [100.00%]
NOTE.—Haplotype frequencies for pairs of alleles were estimated
by the Estimating Haplotype-Frequencies software program, as de-
scribed elsewhere (Terwilliger and Ott 1994).
a x2 (TGT/others) p 18.67, .Pp .000016
used in the present study are available at JSNP. Each
PCR reaction was performed in a 20-ml solution con-
taining 50 pmol of each primer, 10 units of Ex-TaqDNA
polymerase (TaKaRa Shuzo), and 0.55 mg of TaqStart
(Clontech Laboratories) in the GeneAmp PCR system
9700 (Applied Biosystems). Initial denaturation was at
94C for 2 min, followed by 37 cycles of amplification
at 94C for 15 s and annealing at 60C for 45 s, with
final extension for 2 min at 72C.
We genotyped a total of 34 SNPs present in three
selectin genes—13 for E-selectin (SELE 1–13), 15 for L-
selectin (SELL 1–15), and 6 for P-selectin (SELP 1–6)
(fig. 1)—by means of the Invader assay that combines
a structure-specific cleavage enzyme with a universal
fluorescent resonance energy transfer system (Mein et al.
2000).
Comparison of allelic and genotypic frequencies in
patients who have IgAN versus frequencies in control
subjects disclosed significant associations between IgAN
and eight SNPs present in two of the selectins (table 1
and table 2). Among the disease-associated SNPs, two
were in the E-selectin gene (SELE8 in exon 9 and SELE13
in the 3′ flanking region). The other six were in the L-
selectin gene (SELL1 in the 5′ flanking [promoter] region,
SELL4 in intron 2, SELL5 in exon 3, SELL6 in intron
3, SELL10 in exon 5, and SELL11 in intron 5). These
eight SNPs all lie within a 24-kb span of genomic DNA
in the region harboring the three-gene cluster of selectins
on chromosome 1q24-25 (fig. 1).
Homozygosity for minor alleles was significantlymore
common among patients with IgAN than among control
subjects. The most significant association of a single SNP
with IgAN involved SELL6 (x2p22.0, ,Pp .000003
odds ratio 3.42 [95% CI 2.00–5.85]). Among the eight
SNPs for which we found positive associations, two alter
amino acid sequences: SELE8 substitutes tyrosine for
histidine at codon 468 in the short consensus-repeat do-
main of E-selectin ( , , odds ratiop2x p 9.02 Pp .0026
2.73 [95% CI 1.38–5.38]), and SELL10 substitutes ser-
ine for proline at codon 238 in a short consensus-repeat
domain of L-selectin ( , 1, odds ra-2x p 17.4 Pp .00003
tio p 3.61 [95% CI 1.91–6.83]). A third SNP in the
promoter region, SELL1, could affect promoter activity
of the L-selectin gene ( , , odds2x p 19.5 Pp .000010
ratio p 3.77 [95% CI 2.02–7.05]).
Analysis of linkage disequilibrium (LD) coefficients
among these eight SNPs indicated quasi-complete LD
(table 3). When we estimated haplotypes for three SNPs
(SELE8, SELL1, and SELL10) that may affect the quality
and quantity of the gene products, the TGT haplotype
revealed a stronger association with the IgAN phenotype
( , , odds ratio of 1.88 [95% CI2x p 18.67 Pp .000016
1.41–2.51]) than did the genotype at either locus singly
(table 4).
To investigate a potential role of E-selectin and/or L-
selectin in the pathogenesis of IgAN, we performed im-
munohistological staining of these molecules in biopsy
specimens (fig. 2). Strong staining of both E-selectin and
L-selectin was observed in interstitial infiltrates of renal
tissue from a patient with IgAN, whereas staining of
both selectins was very weak in the renal tissues without
infiltration.
In the present study, we have demonstrated significant
association of eight SNPs in selectin genes with IgAN,
as well as accumulation of two selectin proteins in renal
tissues. Our findings suggest that one or more of the
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Figure 2 Immunohistochemical localization of E-selectin and L-selectin in the renal tissues of patients with IgAN. Control tissues were
normal portions obtained from patients who underwent nephrectomy because of renal tumor. The monoclonal antibodies used in this study
were anti-human E-selectin (clone 1.2B6) and anti-human L-selectin (clone FMC46) (DAKO Japan). A, Control E-selectin. B, IgAN E-selectin.
C, Control L-selectin. D, IgAN L-selectin. Original magnification #200.
three specific SNPs could affect the quality or quantity
of the gene products and could play a significant role in
the etiology of IgAN.
Although a genomewide analysis that used familial
cases has been reported (Gharavi et al. 2000), most pa-
tients with IgAN have no familial history of the disease.
IgAN is a complex disease whose etiology involves im-
munological, environmental, and genetic factors (Hsu et
al. 2000). Since it was hard for us to locate patients with
familial histories of IgAN, we chose to perform a case-
control association study, using SNPs at the three-gene
selectin complex on chromosome 1q24-25.
One study suggested that LD in the human genome
was likely to extend only a few kilobases (Dunning et
al. 2000), but other investigators have suspected that it
could extend much farther, to distances 1100 kb in some
cases (Abecasis et al. 2001). In fact, we now know that
distances encompassing LD can vary according to the
chromosomal regions and/or the populations examined
(Reich et al. 2001). We found that LD at the selectin
locus extended over ∼24 kb. This result implies that
∼125,000 SNPs will be required for whole-genome scan-
ning in the Japanese population.
Selectins are cell-cell adhesion molecules involved in
the leukocyte–endothelial cell interaction that is required
for extravasation at sites of tissue injury. They have a
single C-type lectin domain at their extracellular amino-
termini, followed by an epidermal growth factor (EGF)-
like domain, short consensus repeat domains, a trans-
membrane domain, and a short cytoplasmic tail. In the
E-selectin gene, substitutions from Ser to Arg at codon
149 in the EGF-like domain and from Leu to Phe at
codon 575 in the transmembrane domain have been
associated with severe atherosclerosis in German pa-
tients (Wenzel et al. 1996). However, in our Japanese
population sample, we found no substitutions at co-
don 149 and no significant association between IgAN
and the SNP (SELE10) at codon 575 of E-selectin.
Instead, in patients with IgAN we found a significant
increase in tyrosine alleles at codon 468 in E-selectin,
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and in serine alleles at codon 238 in L-selectin, both of
them in short consensus-repeat domains. Certain alleles
of these two SNPs are likely to increase susceptibility to
the IgAN phenotype with interstitial infiltration. The
accumulation of these two isoforms of selectin that we
observed in IgAN kidneys may provide a useful clue for
development of novel treatments for this form of
glomerulonephritis.
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